Lion Biotechnologies' Reverse Merger Round

Lion Biotechnologies raised a round of funding on July 25, 2013. Investors include Genesis Biopharma.

Lion Biotechnologies is a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers. The company's lead product candidate is…

Articles about Lion Biotechnologies' Reverse Merger Round: